KYIV. Nov 18 (Interfax-Ukraine) – The National Agency on Corruption Prevention (NACP) has determined corruption risks that may arise due to limiting the circulation of medicines in wartime, patients and experts warn that the uncertain criteria for the approach to restricting the circulation of Russian and Belarusian drugs create risks of artificially redistribution of the pharmaceutical market, participants of a press conference hosted by the Interfax-Ukraine News Agency on Friday said.